# Quinovic Acid Enhances the Cytotoxicity of KHYG‐1 Cells by Modulating the Ras/MAPK Signalling Pathway and Interferon‐Gamma Expression

**Authors:** Ming‐Ju Hsieh, Jen‐Tsun Lin, Yi‐Ching Chuang, Hsin‐Yu Ho, Yu‐Sheng Lo, Chia‐Chieh Lin, Mu‐Kuan Chen

PMC · DOI: 10.1111/jcmm.70957 · 2025-11-26

## TL;DR

Quinovic acid boosts natural killer cell activity against cancer cells by enhancing cytotoxic molecules and inducing apoptosis.

## Contribution

Quinovic acid is shown to enhance NK cell cytotoxicity via modulation of Ras/MAPK and DNA repair pathways.

## Key findings

- Quinovic acid increases perforin, granzymes, and Fas ligand expression in KHYG-1 cells.
- Quinovic acid induces apoptosis in K562 and other cancer cells by promoting caspase and PARP activation.
- Quinovic acid enhances interferon-gamma secretion through activation of Ras/MAPK and PI3K/AKT/mTOR pathways.

## Abstract

Quinovic acid is a key constituent of cat's claw (Uncaria tomentosa) extract and exhibits antioxidant and anti‐inflammatory activities. In this study, we investigated the potential of quinovic acid to enhance natural killer (NK) cell activity by using the KHYG‐1 cell line. Our data indicated that quinovic acid increased the expression levels of cytolytic molecules, including perforin, granzymes A and B, Fas ligand, and granulysin, and induced the phosphorylation of the transcription factors CREB and STAT4, thereby enhancing cytotoxic activity against K562 cells. Furthermore, when KHYG‐1 cells were cocultured with K562 cells in the presence of quinovic acid, we observed an increase in the expression of t‐Bid, cleaved caspases 3, 8, and 9, and PARP, promoting apoptosis in K562 cells. Quinovic acid also reduced the expression of SET, Ape1, and HMGB2, effectively inhibiting the DNA repair mechanism in target cells. Similar results were observed in other cancer cell lines. In addition, quinovic acid induced interferon‐gamma secretion by upregulating the Ras/MAPK and PI3K/AKT/mTOR signalling pathways through the activation of NKG2D and other NK receptors. These effects were observed not only in KHYG‐1 cells but also in NK cells derived from adult patients with head and neck squamous cell carcinoma. Our findings suggest that quinovic acid enhances NK cell cytotoxicity, showing promise as a potential therapeutic against various cancer cell types.

## Linked entities

- **Genes:** PRF1 (perforin 1) [NCBI Gene 100113473], LOC102397020 (antimicrobial peptide NK-lysin) [NCBI Gene 102397020], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385], STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 6775], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], SET (SET nuclear proto-oncogene) [NCBI Gene 6418], APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328], HMGB2 (high mobility group box 2) [NCBI Gene 3148], ras (resistance to audiogenic seizures) [NCBI Gene 19412], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914]
- **Chemicals:** Quinovic acid (PubChem CID 120678)
- **Diseases:** head and neck squamous cell carcinoma (MONDO:0010150)
- **Species:** Uncaria tomentosa (taxon 128375)

## Full-text entities

- **Genes:** APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HMGB2 (high mobility group box 2) [NCBI Gene 3148] {aka HMG2}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, FASLG (Fas ligand) [NCBI Gene 356] {aka ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 6775] {aka DPMC, SLEB11}, GNLY (granulysin) [NCBI Gene 10578] {aka D2S69E, LAG-2, LAG2, NKG5, TLA519}
- **Diseases:** cancer (MESH:D009369), head and neck squamous cell carcinoma (MESH:D000077195), Cytotoxicity (MESH:D064420), inflammatory (MESH:D007249)
- **Chemicals:** Quinovic Acid (MESH:C472605)
- **Species:** Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606], Uncaria tomentosa (species) [taxon 128375]
- **Cell lines:** KHYG-1 — Homo sapiens (Human), Natural killer cell lymphoblastic leukemia/lymphoma, Cancer cell line (CVCL_2976), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12648300/full.md

---
Source: https://tomesphere.com/paper/PMC12648300